Previous close | 5.80 |
Open | 6.10 |
Bid | 8.11 x 1000 |
Ask | 0.00 x 0 |
Day's range | 5.70 - 8.11 |
52-week range | 4.98 - 13.10 |
Volume | |
Avg. volume | 126,558 |
Market cap | 33.161M |
Beta (5Y monthly) | 0.34 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.03 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significant control over Redwoods Acquisition by retail investors implies that the general public has more...
ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSI